Clinical trial
Flecainide-Short Long Study (Flec-SL)
NCT00215774 · Atrial Fibrillation Network, Other · Completed
Key facts
| NCT number | NCT00215774 |
|---|---|
| Title | Flecainide-Short Long Study (Flec-SL) |
| Official title | Targeted Pharmacological Reversal of Electrical Remodeling After Cardioversion. |
| Lead sponsor | Atrial Fibrillation Network, Other |
| Collaborators | German Federal Ministry of Education and Research Meda Pharmaceuticals Industry German Research Foundation |
| Status | Completed |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | Flecainide |
| Enrollment | 760 |
| Start date | Mar 1, 2005 |
| Primary completion | Oct 1, 2009 |
| Completion | Mar 1, 2011 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 11, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: